Dolomite Bio, a leading provider of high throughput single cell technology, and Partek Incorporated, a recognized leader in the development of powerful genomic data analysis tools – today announced a collaboration to combine Partek’s single cell data analysis capabilities with Dolomite Bio’s microfluidic droplet-based single cell technology.
Application specialist and coffee lover. When not in the office or the lab, you will find Juliane in a yoga class or salsa dancing. Prior to working at Dolomite Bio, Juliane did a PhD in microbiology at the leibniz institute for natural product research and infection biology.
The Single Cell Biology conference took place last week in Cambridge, UK. Paul Oakley, our Regional Manager for the UK and Muriel Breteau, one of our Application Specialists were lucky enough to join this meeting.
Single-cell RNA-sequencing (scRNA-seq) is a cutting edge innovative technology that provides unprecedented insight into the expression patterns of thousands of single cells. Individually analyzing thousands of single cells from a tissue can vastly improve the understanding of biological systems to derive vital information about diseases and immunity.
Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights.